Carlos MoranSegura

19PUBLICATIONS
143CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunityMolecular targetsCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 20, 2026
Spatial Clustering of Recently Activated Cytotoxic Lymphocytes Improves Association with Overall Survival in Women with High-Grade Serous Ovarian Cancer.

|Apr 14, 2026
Spatial Clustering of Recently Activated Cytotoxic Lymphocytes Improves Association with Overall Survival in Women with High-Grade Serous Ovarian Cancer.

Alex C Soupir, Mary K Townsend, Cassandra A Hathaway

|Apr 04, 2025
Human Immunodeficiency Virus-Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers.

Jordan Fenlon, Nathan Van Bibber, Jonathon Mahlow

|Nov 13, 2024
Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas.

Lilit Karapetyan, Aofei Li, Danielle Vargas De Stefano

|Nov 09, 2024
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial.

Roger Li, Nancy Y Villa, Xiaoqing Yu

Pageof 4